This inventor holds 1 USPTO granted patent. Top assignee: The Ohio State University. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Inventor Spotlight: Caroline C. Whitacre
Introduction
Caroline C. Whitacre is an accomplished inventor based in Columbus, Ohio, who has made significant contributions to the field of immunology. With her expertise, she has created innovative solutions aimed at combating T cell-mediated immune reactions, an area critical for the treatment of autoimmune diseases.
Latest Patents
Whitacre holds a patent for "CD28 mimetics for blocking T cell mediated immune reactions." This patent provides agents, specifically peptides known as 'CD28 peptide mimetics' ranging from 15 to 30 amino acids in length. These peptides include the hexapeptide motif 'MYPPPY' and its retro-inverso isomer. In addition, the peptide mimetics feature a flanking sequence at both the amino and carboxyl terminus of the hexapeptide motif. The invention also describes methods for administering these mimetics to treat subjects suffering from T cell-mediated autoimmune diseases or disorders.
Career Highlights
Whitacre’s career has been driven by her dedication to research and innovation in her field. As an esteemed member of The Ohio State University, she has contributed to advancing the understanding of immune responses and exploring therapeutic avenues for complex health issues.
Collaborations
Throughout her career, Caroline has collaborated with esteemed colleagues, including Pravin T. P. Kaumaya and Mythily Srinivasan. These collaborations exemplify the interdisciplinary approach needed in the research community to tackle pressing medical challenges.
Conclusion
Caroline C. Whitacre's work exemplifies the vital role of innovation in medicine. Through her patented technology and collaborations, she continues to influence the research landscape, paving the way for new treatments for autoimmune diseases and enhancing the quality of life for those affected.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

